Med. Pro Praxi 2009; 6(5): 281-283

Intravenous implantable ports in the hematooncology

Bc. Monika Labudíková, MUDr. Jaromír Hubáček, Ph.D, Bc. Andrea Jablunková, Jana Lišková
Hemato-onkologická klinika FN a LF UP v Olomouci

The article reviews the knowledge about intravenous implantable ports. We are using this methods since 1997. The diagnosis

non-Hodgkin’s lymphoma is first of candidates to implantation intravenous implantable ports. The article in detail describe the methods

of implantation and describe various complications. Infection is the most frequent and serious complication associated with intravenous

therapy. The education (client preparation) before achievement is necessery, improve the comfort of patiens. Nursing staff must

be know the routine sterile procedures, must be assessment complications to the improving long time existence of port.

Keywords: intravenous port, implantation of port, attendance, complication.

Published: December 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Labudíková M, Hubáček J, Jablunková A, Lišková J. Intravenous implantable ports in the hematooncology. Med. praxi. 2009;6(5):281-283.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Grundy M. Nursing in Hematological Oncology. Bailliere Tindall: Royal College of Nursing, UK, 2000: 314 s.
    2. Fotodokumentace Hemato-onkologické kliniky Fakultní nemocnice Olomouc.
    3. Boldis P. Bibliografické citace dokumentů podle ISO 690 a ISO 690-2./online/./cit. 2004-11-11/. URL: http://www.boldis.cz/citace/citace.html
    4. Vokurka S. Ošetřovatelské problémy a základy hemoterapie. Praha: Galén, 2005: 140 s.
    5. Faber E, et al. Komplikácie centrálnej venóznej aplikácie u hematologických chorých - prospektívna studia 193 kanylácií. Vnitřní Lék. 1994; 40: 765-769.
    6. Hájek R, et al. Podkožní aplikační systém (port) při dlouhodobé léčbě onkologických nemocných. Vnitřní Lék., 1995; 41(1): 21-27.
    7. Hubáček J, et al. Venózní porty u hemato-onkologických pacientů. Naše první zkušenosti. Praktický lékař, 1999; 79(11).
    8. Fricová J, Stříteský M. Implantabilní intravenózní porty. Bolest, 2006; 9(3): 176-183.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.